XORTX Therapeutics Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
XORTX Therapeutics has a total shareholder equity of $2.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.8M and $2.1M respectively.
Wichtige Informationen
0%
Verhältnis von Schulden zu Eigenkapital
US$0
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | US$3.08m |
| Eigenkapital | US$2.70m |
| Gesamtverbindlichkeiten | US$2.09m |
| Gesamtvermögen | US$4.80m |
Jüngste Berichte zur Finanzlage
Recent updates
Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation
Aug 23
XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business
Apr 01We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow
Dec 16Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth
Sep 01Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: XRTX's short term assets ($3.4M) exceed its short term liabilities ($437.9K).
Langfristige Verbindlichkeiten: XRTX's short term assets ($3.4M) exceed its long term liabilities ($1.7M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: XRTX is debt free.
Schulden abbauen: XRTX has no debt compared to 5 years ago when its debt to equity ratio was 227.9%.
Bilanz
Liquiditätsreserve-Analyse
Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.
Stabile Start- und Landebahn für Bargeld: XRTX has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Vorhersage Cash Runway: XRTX is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.